Muroran Institute of Technology · Graduate School of Engineering · 特任准教授

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Retinal Pigment Epithelium Specific Metabolic Phenotypes Are Regulated by High-Mobility Group Protein N1 Toshiaki Abe, Reiko Daigaku, Xie Yuting, Yasukazu Daigaku, Nobuhiro Nagai, Hirokazu Kaji,3 Aya Katsuyama, Yuki Katsukura, Yasuko Izumida, Atsuko Suzuki, Shinji Yamada, Yao-Wen Chang, Keiko Terada, Sei-ichi Ishiguro, Noriko Osumi, Hiroshi Kunikata,5 and Toru Nakazawa.，Investigative Ophthalmology & Visual Science，66巻，4号，(頁 70 ～ )，2025年2025 · 論文
• New paradigm for long-acting retinal drug delivery: An unoprostone-release device for the treatment of retinitis pigmentosa Nobuhiro Nagai, Hirokazu Kaji, Toshiaki Abe，Advances in Vision Research, Volume IV: Translations Research - Developing Therapeutics and Diagnostics for Genetic Eye Diseases，(頁 285 ～ 294)，2024年2024 · 論文
• Minimally invasive sub-retinal transplantation of RPE-J cells on a biodegradable composite PCL/collagen nanosheet Kazuya Yamashita, Sergo Ostrovidov, Bibek Raut, Takeshi Hori, Yuji Nashimoto, Nobuhiro Nagai, Toshiaki Abe, Hirokazu Kaji，Cell Transplantation，32巻，(頁 1 ～ 16)，2023年2023 · 論文
• A comparative study between a transscleral sustained-release device and eyedrops on intraocular distribution of carteolol hydrochloride Yoshiko Hashikawa, Yuki Kato, Hirokazu Kaji, Toshiaki Abe, Nobuhiro Nagai，Heliyon，(頁 e14392 ～ )，2023年2023 · 論文

• 低侵襲で多剤動態制御可能な薬物徐放デバイスの開発と網膜疾患治療への応用
• 網膜変性疾患治療用の薬物徐放性に優れた「強膜上移植型」インプラントの開発
• ドラッグデリバリーシステム
• サケ皮由来伸縮性コラーゲンを用いた生体置換型人工血管の開発

• Official profile